SCHEMBL169942

SCHEMBL169942

OCc1cccc(OCC2CO2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.72
ALDH1A1 P00352 4/20 0.72
TP53 P04637 3/20 0.72
SMN1; SMN2 Q16637 2/20 0.72
HIF1A Q16665 2/20 0.72
CYP3A4 P08684 1/20 0.72
TDP1 Q9NUW8 1/20 0.59
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
PPARG P37231 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
GPBAR1 Q8TDU6 1/20 0.43
CYSLTR1 Q9Y271 1/20 0.43
GLA P06280 1/20 0.42
FGFR1 P11362 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8795299 1.00 TSHR (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL19828239 0.85 ALDH1A1 (0.74) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL37802 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL31537002 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL31537008 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL12289601 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL13806572 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL16527504 0.84 ALDH1A1 (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL22855755 0.84 ALDH1A1 (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL27697987 0.84 ALDH1A1 (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2862916-A1 Alkoxylated quaternary ammonium salts and fuels containing them Afton Chemical Corporation (US) 2015-04-22 EP claimed
US-20150096516-A1 ALKOXYLATED QUATERNARY AMMONIUM SALTS AND FUELS CONTAINING THEM AFTON CHEMICAL CORPORATION (US) 2015-04-09 US claimed
US-8992636-B1 Alkoxylated quaternary ammonium salts and fuels containing them AFTON CHEMICAL CORPORATION (US) 2015-03-31 US claimed
US-8114519-B2 Derivatized solid epoxy resin and uses thereof SIKA TECHNOLOGY AG (CH) 2012-02-14 US claimed
US-20100035041-A1 DERIVATIZED SOLID EPOXY RESIN AND USES THEREOF SIKA TECHNOLOGY AG (CH) 2010-02-11 US claimed
EP-2084200-B1 DERIVATIZED SOLID EPOXY RESIN AND USES THEREOF SIKA TECHNOLOGY AG (CH) 2009-12-30 EP claimed
EP-2084200-A1 DERIVATIZED SOLID EPOXY RESIN AND USES THEREOF Sika Technology AG (CH) 2009-08-05 EP claimed
WO-2008049860-A1 DERIVATIZED SOLID EPOXY RESIN AND USES THEREOF SIKA TECHNOLOGY AG (CH) 2008-05-02 WO claimed
EP-1916285-A1 Derivatized solid epoxy resin and its use Sika Technology AG (CH) 2008-04-30 EP claimed
US-20260139170-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION SIKA TECHNOLOGY AG (CH) 2026-05-21 US disclosed
US-12552908-B2 Thermally expandable compositions comprising a chemical blowing agent SIKA TECHNOLOGY AG (CH) 2026-02-17 US disclosed
US-12534587-B2 Thermally expandable compositions comprising a chemical blowing agent SIKA TECHNOLOGY AG (CH) 2026-01-27 US disclosed
US-12522706-B2 Thermally expandable compositions comprising an endothermic blowing agent SIKA TECHNOLOGY AG (CH) 2026-01-13 US disclosed
EP-4626995-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION Sika Technology AG (CH) 2025-10-08 EP disclosed
US-5717054-A QUICK-SETTING NATIONAL STARCH & CHEMICAL INVESTMENT HOLDING CORP. (US) 1998-02-10 US disclosed
EP-0611003-B1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO INC (US) 1997-06-18 EP disclosed
EP-0747371-A1 Epoxy resins consisting of flexible chains terminated with glycidyloxyphenyl groups for use in microelectronics adhesives National Starch and Chemical Investment Holding Corporation (US) 1996-12-11 EP disclosed
US-5451677-A Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1995-09-19 US disclosed
EP-0611003-A1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO. INC. (US) 1994-08-17 EP disclosed
US-4039685-A 1-PHENOXY-2-HYDROXY-3-TERT.-BUTYLAMINO PROPANE ANTIARRHYTHMIC COMPOUNDS BOEHRINGER INGELHEIM GMBH (DT) 1977-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552908-B2 Thermally expandable compositions comprising a chemical blowing agent CA1, CA3, CA12 TSHR 4237/4885ALDH1A1 1546/4885TP53 1344/4885
US-20150096516-A1 ALKOXYLATED QUATERNARY AMMONIUM SALTS AND FUELS CONTAINING THEM ALKBH3, AGT, ALK TSHR 4251/4885ALDH1A1 308/4885TP53 3939/4885
US-20260139170-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION DDAH1, ACMSD, APEH TSHR 4763/4885ALDH1A1 433/4885TP53 3423/4885
US-12534587-B2 Thermally expandable compositions comprising a chemical blowing agent OGG1, GRN, TAF1 TSHR 4739/4885ALDH1A1 3539/4885TP53 2740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.